A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT06470438 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06470438
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Refractory B-Cell NHL Relapsed B-cell NHL

Start date: 2024-05-28
Primary completion: 2027-10-29
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.